Allergic Bronchial Asthma is recurring episodes of wheezing, chest tightness, coughing, and shortness of breath. This is a chronic inflammatory disorder that is usually triggered by an allergic response to specific allergens, such as dust, mites, pet dander, insect stings, molds, or pollen. A few other things can worsen your condition, including viral respiratory infections, stress, weather conditions, irritants in the air, exercise, and certain food additives.
Medications to control symptoms and prevent attacks, such as:
Avoidance of allergens and triggers.
Environmental control measures, such as- removing carpets and rugs, using allergen-proof bedding, controlling indoor humidity and avoiding exposure to tobacco smoke and air pollution.
Effective management of allergic bronchial asthma requires a comprehensive approach, includes:
By understanding the causes, triggers, and treatment options for allergic bronchial asthma, individuals can better manage their symptoms and improve their quality of life.
Pulmonary hypertension refers to increased blood pressure in the arteries that carry blood from the heart to the lungs. This elevated pressure makes it difficult for the heart to function properly and, if left untreated, can lead to heart failure.
This condition can result from various factors, including lung diseases such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, heart conditions, sleep apnea, blood clots in the lungs, and certain medications.
Interstitial Lung Disease, or ILD, is a group of respiratory disorders affecting the interstitium (lung tissue) and the space around the alveoli (air sacs). ILD refers to a group of lung disorders that cause scarring and inflammation in the lungs. This scarring may affect not only the alveolar epithelium but also the pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. As a result of this scarring and inflammation, breathing becomes difficult, and oxygen supply to the bloodstream is compromised. ILD serves as an umbrella term encompassing over 200 conditions classified by histopathological, radiologic, and clinical parameters. Since 2015, approximately 1.9 million people were affected due to this disorder, and 122000 death attributed to ILD in the year.
Respiratory failure
Bronchiectasis is a long-term, chronic lung condition in which the airways become widened, leading to an excess buildup of mucus that makes the lungs more vulnerable to infections. It is often associated with cystic fibrosis. While most people with bronchiectasis can manage the condition and reduce their risk of lung infections, repeated infections can further damage the airways, and there is currently no cure.
The condition may take months or years to develop noticeable signs or symptoms. Once symptoms are diagnosed, the condition may already have worsened. Diagnosis typically involves assessing family history and conducting blood tests to determine any underlying causes of bronchiectasis. Early diagnosis can help prevent extensive lung damage.
Although there is no cure for bronchiectasis, early diagnosis and treatment can help prevent further deterioration of lung function. Patients with bronchiectasis are advised to consult a general practitioner if they develop a persistent cough or to seek help from a specialist for further testing and treatment.
Untreated bronchiectasis can lead to serious complications, such as brain abscesses, collapsed lungs, and heart failure. It is essential to seek medical attention before symptoms worsen or any new symptoms appear.
Tuberculosis, or TB, also known as “white death,” is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Although this disease can occur with or without symptoms, it primarily attacks the lungs and can slowly spread to other parts of the body. Active TB cases are 50% fatal if untreated.
Before seeking medical help, it is essential to understand the different types of Tuberculosis:
While TB is caused by Mycobacterium tuberculosis, it spreads through the air when patients with active TB cough, sneeze, or speak. Note that Latent TB has no symptoms and is not contagious, while Active TB is infectious and spreads easily.
Active TB— Fever, Night sweats, Weight loss, Fatigue, and Loss of appetite
Pulmonary TB (Lung-related symptoms)– Chronic cough (often with blood-stained mucus), Chest pain, Shortness of breath, and Coughing up blood (in rare cases)
Extrapulmonary TB (Symptoms vary based on affected organs)–
Symptoms depend on the specific organ involved (e.g., pleura, lymphatic system, central nervous system, or bones).
Certain conditions increase the likelihood of developing TB:
MDR-TB is a form of tuberculosis that is resistant to at least two first-line anti-TB drugs—rifampicin and isoniazid. This resistance typically occurs due to random mutations that alter the quantity and structure of intracellular drug targets.